daratumumab
janssen
['leusm', 'lymphoma', 'delphinus']
congress #eha22 | ajay vora reports on the delphinus phase ii study of dara+vpld in pediatric (p) &amp; ya pts with r/r t-all or lymphoblastic lymphoma. n=24, orr was 83.3% in p-, 60.0% in ya-all &amp; 50.0% in ll pts. 41.7% p-all pts achieved mrd negativity #allsm #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm